Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity
Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity
Development and Validation of Stability Indicating Method for Capecitabine
Formulation of Elastic Liposomal Gel of Gaultheria Procumbens For Rheumatoid Arthritis
Anti-Aging Herbal Topical Formulation
Design Synthesis of Small Molecular Inhibitors of hIMPDH2 Inhibitors as Potential Anticancer Agents
Design and Synthesis of Ferulic Acid Derivatives as Anti-Alzheimer’s Agent
Design and Synthesis of Ferulic Acid Derivatives as Anti-Alzheimer’s Agent
Design Synthesis and Evaluation of Acridone Based Derivatives against AKT in GBM
Design, Synthesis and Biological Evaluation of Acridone Based Derivaties as Anticncer
Exploring the role of Ganoderma Lucidum and its major Constituent p-coumaric Acid in Aluminum Chloride (AlCl3) induced Alzheimer’s disease in Experimental Animals
Design Synthesis and Evaluation of Niclosamide Derivatives Anticancer Agents
Development of Validated Stability Indicating Assay Method and Study Decomposition Behaviour of Lenvatinib by LC-MS/MS
Nanotechnology-based Approach for the Detection of Human Chorionic Gonadotrophin in Biofluid
Formulation and evaluation of a transdermal Delivery System of Cariprazine for Schizophrenia
Wrightia Tinctoria Emulgel for Autoimmune disease-Psoriasis
Intranasal Administration of pH-responsive Silibinin-loaded Pullulan Nanoparticles for Alzheimer’s Disease Management
Temozolomide Loaded Gelatin Nanoparticles Incorporated into Polymeric Nanofiber for Sustained Release
Naringenin Microneedles as Theranostics in the management of Rheumatoid Arthritis
Formulation Development and Optimization of Temozolomide Nano Lipid Carriers